Context Therapeutics Inc
General ticker "CNTX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $26.8M (TTM average)
Context Therapeutics Inc does not follow the US Stock Market performance with the rate: -7.4%.
Estimated limits based on current volatility of 8.3%: low 0.63$, high 0.74$
Factors to consider:
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.73$, 2.12$]
- 2025-12-31 to 2026-12-31 estimated range: [0.59$, 1.74$]
Short-term CNTX quotes
Long-term CNTX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $15.38MM | $25.07MM | $29.92MM |
| Operating Income | $-15.38MM | $-25.07MM | $-29.92MM |
| Non-Operating Income | $0.55MM | $1.11MM | $3.20MM |
| R&D Expense | $7.59MM | $17.78MM | $22.70MM |
| Income(Loss) | $-14.84MM | $-23.96MM | $-26.73MM |
| Profit(Loss)* | $-14.29MM | $-23.96MM | $-26.73MM |
| Stockholders Equity | $34.76MM | $11.87MM | $95.27MM |
| Assets | $37.97MM | $16.06MM | $98.13MM |
| Operating Cash Flow | $-13.55MM | $-21.05MM | $-14.56MM |
| Capital expenditure | $0.54MM | $0.00MM | $14.76MM |
| Investing Cash Flow | $-0.54MM | $0.00MM | $-14.76MM |
| Financing Cash Flow | $-0.10MM | $0.00MM | $109.29MM |
| Earnings Per Share** | $-0.90 | $-1.50 | $-0.46 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.